Bestyrelsen for Investeringsforeningen Maj Invest har på et bestyrelsesmøde d.d. godkendt halvårsrapporten for første halvår 2026.
Den godkendte rapport kan ses nedenfor.
Venlig hilsen
Investeringsforeningen Maj Invest
Bestyrelsen for Investeringsforeningen Maj Invest har på et bestyrelsesmøde d.d. godkendt halvårsrapporten for første halvår 2026.
Den godkendte rapport kan ses nedenfor.
Venlig hilsen
Investeringsforeningen Maj Invest
A concise daily briefing of key stories, insights and developments, selected by our editorial team.
By subscribing, you agree to our Privacy Policy. Unsubscribe at any time.
Cergy, October 28 st , 2026 – SPIE, the independent European leader in multi-technical services in the areas of energy and communications, has signed an agreement to acquire SAR ANLAGENBAU GmbH (SAR), significantly expanding its electrical service portfolio into highly attractive areas of infrastructure and industrial automation systems in Austria and Germany. Under the agreement, SPIE will acquire a 76% stake in SAR ANLAGENBAU GmbH, while SAR ’ s Managing Director and Shareholder Arno Reisinger
NORWALK, Conn., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NYSE American: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, today announced that it has entered into a securities purchase agreement with its majority investor, D&D Source of Life Holding Ltd., for the purchase and sale of 17,421,602 shares of its common stock at a purchase price of $0.574 per share in a private investment in public equity (“PIPE”) financing pri
The guide encourages sellers to define goals, choose sales channels, strengthen product listings and use performance data to refine their approach. Kortrijk, WEST FLANDERS, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Crosslist, a leading software tool for online sellers , has outlined a practical approach to creating an e-commerce strategy designed to help businesses make deliberate decisions before investing time and resources in selling online. The guidance covers goal-setting, market research, platform
First nine months 2026: structural improvement of profitability Q3 2026 revenues: €121.6 million (stable / -2%)* Q3 2026 EBITDA before non-recurring items: €23.4 million (+10% / +10%)*, representing a margin of 19.3%, up 200 basis points 2026 growth in SaaS ARR and recurring contract revenues expected below 2026-2028 roadmap ambitions** Contribution from the structural increase in 2026 EBITDA margin before non-recurring items to exceed the 120 to 180 basis points improvement target** (*) Change
Availability of the quarterly financial report at September 30, 2026 Paris, October 28, 2026 – Lectra informs its shareholders, in compliance with article 221-4-IV of the General Regulation of the Autorité des marchés financiers , that the quartely financial report at September 30, 2026, is available on Lectra’s website: www.lectra.com/en/investors . About Lectra Lectra sparks customer transformation. The Group offers solutions that combine software, cutting equipment, data, and services, levera
Company Announcement No. 20 - 2026 to Nasdaq Copenhagen 2026.10.28 Interim Financial Report for the Period 1 January - 30 September 2026 AO delivered strong revenue growth and improved earnings in the third quarter of 2026. Revenue increased by 22.9% to DKK 1,800m, while EBITDA increased by 28.0% to DKK 126m. The EBITDA margin improved to 7.0% from 6.7% in Q3 2025. EBITDA was affected by transaction costs of DKK 17.5m; excluding these costs, the EBITDA margin was 8.0%. Market activity remained h
The global dermatological therapeutics market is expected to grow steadily, driven by the rising prevalence of acne, psoriasis, atopic dermatitis, and other chronic skin disorders. Growing awareness of skin health and increasing demand for effective and targeted treatments are supporting market expansion. The adoption of biologics, JAK inhibitors, and other advanced therapies is further transforming the treatment landscape. In addition, increased healthcare spending, improved diagnosis, and ongo
Revenue growth and cost discipline amid challenging external conditions Q3 2026 Key Operating Results Sales of goods and services amounted to ISK 51,147 million, up 8.6% year-on-year. Margin from sales of goods and services amounted to ISK 11,901 million, down 1.3% year-on-year. Margin level was 23.3%, down 2.3 p.p. year-on-year, or 0.8 p.p. excluding the effects of changes in exchange rates, fuel prices and public levies on fuel. EBITDA amounted to ISK 4,988 million, down 6.2% year-on-year. Pro
Comments (0)
Login to join the conversation
Login / RegisterNo comments yet. Be the first to comment!